Evaluation of Blood Pressure Reduction Response and Responder Characteristics to Fixed‐Dose Combination Treatment of Amlodipine and Losartan: A Post Hoc Analysis of Pooled Clinical Trials. Issue 9 (7th August 2014)
- Record Type:
- Journal Article
- Title:
- Evaluation of Blood Pressure Reduction Response and Responder Characteristics to Fixed‐Dose Combination Treatment of Amlodipine and Losartan: A Post Hoc Analysis of Pooled Clinical Trials. Issue 9 (7th August 2014)
- Main Title:
- Evaluation of Blood Pressure Reduction Response and Responder Characteristics to Fixed‐Dose Combination Treatment of Amlodipine and Losartan: A Post Hoc Analysis of Pooled Clinical Trials
- Authors:
- Unniachan, Sreevalsa
Wu, David
Rajagopalan, Srinivasan
Hanson, Mary E.
Fujita, Kenji P. - Abstract:
- <abstract abstract-type="main" id="jch12390-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Data from four clinical trials compared reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) among patients treated with amlodipine/losartan 5/50 mg vs 5/100 mg and amlodipine/losartan 5/50 mg vs amlodipine 5 mg and 10 mg. Response rate was assessed as reduction in SBP or DBP (>20/10 mm Hg) and proportion of patients achieving SBP <140 mm Hg or DBP <90 mm Hg. Patients were grouped into quartiles based on baseline SBP and DBP. Mean SBP and DBP were reduced in amlodipine/losartan 5/50 mg (n=182) and amlodipine/losartan 5/100 mg (n=95) users across all baseline quartiles. Patients using amlodipine/losartan 5/50 mg had significantly greater SBP and DBP reductions vs amlodipine 5 mg (<italic>P</italic>=.001 and <italic>P</italic>=.02, respectively). Amlodipine/losartan 5/50 mg users had significantly greater SBP reduction vs amlodipine 10 mg (SBP <italic>P</italic>=.02; DBP <italic>P</italic>=not significant). The odds of responding to therapy were significantly greater with amlodipine/losartan 5/50 mg vs amlodipine 5 mg (odds ratio, 5.33; 95% confidence interval, 1.42–25.5) and were similar vs amlodipine 10 mg (odds ratio, 0.67; 95% confidence interval, 0.017–9.51). These results support the use of combination therapy early in the treatment of hypertension.</p> </abstract>
- Is Part Of:
- Journal of clinical hypertension. Volume 16:Issue 9(2014:Sep.)
- Journal:
- Journal of clinical hypertension
- Issue:
- Volume 16:Issue 9(2014:Sep.)
- Issue Display:
- Volume 16, Issue 9 (2014)
- Year:
- 2014
- Volume:
- 16
- Issue:
- 9
- Issue Sort Value:
- 2014-0016-0009-0000
- Page Start:
- 671
- Page End:
- 677
- Publication Date:
- 2014-08-07
- Subjects:
- Hypertension -- Periodicals
616.132 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1751-7176 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/loi/jch ↗ - DOI:
- 10.1111/jch.12390 ↗
- Languages:
- English
- ISSNs:
- 1524-6175
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4958.484100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3701.xml